Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-127227
Abstract: Introduction: Plinabulin (Plin) is being developed as a novel non-Granulocyte colony stimulating factor (G-CSF) for CIN prevention. Previously we reported that Plin was equally effective as Pegfilgrastim for the prevention of grade 4 CIN in…
read more here.
Keywords:
cin;
doc;
chemo induced;
prevention ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e12017
Abstract: e12017 Background: Peg is used for CIN prevention. Plin, a novel, non-G-CSF agent is in Phase (Ph) 3 trials for CIN prevention and as an anticancer (NSCLC) agent. In contrast to Peg, Plin does not…
read more here.
Keywords:
bone pain;
plin;
peg;
dose peg ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.8_suppl.4
Abstract: 4 Background: Peg is a long-acting G-CSF used for prevention of Chemotherapy Induced Neutropenia (CIN). Peg stimulates granulopoiesis in bone marrow and causes a temporary overshoot in absolute neutrophil count (ANC). High NLR is a…
read more here.
Keywords:
immune suppressive;
plin peg;
nlr lmr;
plin ... See more keywords